cometis Logo
  • Career
  • Team
  • References
  • English
    • Deutsch
  • About
    • OVERVIEW
    • Profile
    • Team
    • Responsibility
    • References
      • OVERVIEW
      • Investor Relations
      • ESG
      • IPO
      • Bond
      • M&A
      • Public Relations
      • Crisis Communication
      • Corporate Publishing
    • Awards
    • Career
      • OVERVIEW
      • Blog
  • Services
    • OVERVIEW
    • Investor Relations
      • OVERVIEW
      • IR Strategy
        • OVERVIEW
        • Investor Targeting
        • Perception Study
        • Analyst Coverage
        • Analyst Consensus
        • Broker Analysis
        • Supervisory Board Reporting
      • Equity Story
      • Fact Sheet
      • Investor Presentation
      • Annual Report
        • OVERVIEW
        • Guidance & Reporting
      • Peer Group Analysis
      • Media Work
        • OVERVIEW
        • Ad Hoc Communications
        • Corporate News
        • Media Monitoring
        • Video Commentaries
      • Media Training
      • Annual General Meeting
        • OVERVIEW
        • Organisation of the AGM
        • AGM Back Office
        • Management Board Speech
        • Question / Answer Management
        • Corporate Governance
      • Stakeholder ID
      • Investor Access
    • ESG
      • OVERVIEW
      • Stakeholder Engagement
      • ESG-Strategy
        • OVERVIEW
        • ESG-Benchmarking
        • ESG-Workshop
        • ESG-/Sustainability Strategy
        • ESG Data & KPIs
      • ESG-Documents
        • OVERVIEW
        • ESG-Reports
      • ESG-Rating Advisory
      • ESG-Communication
    • IPO
      • OVERVIEW
      • IPO Equity Story
      • IPO Presentation
      • IPO Fact Sheet
      • IPO Media Work
      • Executive Coaching
      • IPO Ad Hoc Announcements
      • IPO Corporate News
      • IPO Media Monitoring
      • IPO Website
      • IPO Prospectus
      • IPO Event
    • Bond
      • OVERVIEW
      • Bond Story
      • Bond Website
      • Bond Fact Sheet
      • Bond Presentation
      • Private Investors
      • Bond Media Work
      • Bond Interview Training
      • Bond Advertising
    • M&A
      • OVERVIEW
      • Communication Strategy
      • Core Messages
      • Leakage Strategy
      • Media Management
      • Mergers and Acquisitions Language Rules
      • Interim Speaker
      • Media Resonance Analysis
      • WPHG Messages
      • Media Documents
      • Internal Communication
      • Customer Communication
      • Offer Website
    • Crisis Communication
      • OVERVIEW
      • Scenario Analysis
      • Crisis Core Messages
      • Crisis Communication Strategy
      • Crisis PR
      • Employee Communication
      • Stakeholder Communication
    • PR
      • OVERVIEW
      • Agenda Setting
      • Core Messages
      • Language Rules
      • CEO positioning
      • Communication Training
      • Press
      • Press Release
      • Studies
      • Panels
      • Events and Conferences
      • Webcast Banner Design
      • Media Planning
      • Reporting
      • Media Analysis
    • Design/Corporate Publishing
      • OVERVIEW
      • Financial Communication
      • Non-Financial Communication
      • Special Editions
  • Newsroom
  • Events
    • OVERVIEW
    • Current
    • Archive
  • Shop
    • OVERVIEW
    • Management Ratios
    • Industry Ratios
    • Financial Ratios Dictionaries
    • Advisor
    • Boxen
    • Special Edition
    • Terms and Conditions
  • English
    • German
June 17, 2020 | Dermapharm Holding SE: Annual General Meeting approves dividend payout of EUR 0.80 per share

June 17, 2020 | Dermapharm Holding SE: Annual General Meeting approves dividend payout of EUR 0.80 per share

by Nicolas Oberndorfer | Jun 17, 2020 | Dermapharm Corporate News, News

Corporate news to the archive Dermapharm Holding SE: Annual General Meeting approves dividend payout of EUR 0.80 per share Annual General Meeting successfully held virtually Management Board and Supervisory Board discharged by a large majority Important milestones...
May 19, 2020 | Dermapharm Holding SE: Growth in the first quarter of 2020 despite the corona pandemic

May 19, 2020 | Dermapharm Holding SE: Growth in the first quarter of 2020 despite the corona pandemic

by Nicolas Oberndorfer | May 19, 2020 | Dermapharm Corporate News, News, Uncategorized

Corporate news to the archive Dermapharm Holding SE: Growth in the first quarter of 2020 despite the corona pandemic Group revenues increased by 17.7% to EUR 192.5 million Adjusted Group EBITDA rose by 13.0% to EUR 49.4 million Corona pandemic leads to increased...
May 19, 2020 | Dermapharm Holding SE: Growth in the first quarter of 2020 despite the corona pandemic

April 8, 2020 | Dermapharm confirms profitable growth in 2019 and presents positive outlook for 2020 despite corona

by Nicolas Oberndorfer | Apr 8, 2020 | Dermapharm Corporate News, News

Corporate news to the archive Dermapharm confirms profitable growth in 2019 and presents positive outlook for 2020 despite corona Significant revenue and earnings growth in 2019 resulted from continuous product development, further internationalization and successful...
May 19, 2020 | Dermapharm Holding SE: Growth in the first quarter of 2020 despite the corona pandemic

March 31, 2020 | Dermapharm successfully acquires Allergopharma

by Nicolas Oberndorfer | Mar 31, 2020 | Dermapharm Corporate News, News

Corporate news to the archive Dermapharm successfully acquires Allergopharma   Grünwald, March 31, 2020 – Dermapharm Holding SE (“Dermapharm”), a leading manufacturer of patent-free branded pharmaceuticals for selected therapeutic areas, successfully...
May 19, 2020 | Dermapharm Holding SE: Growth in the first quarter of 2020 despite the corona pandemic

March 25, 2020 | Dermapharm continues its profitable growth in 2019

by Nicolas Oberndorfer | Mar 30, 2020 | Dermapharm Corporate News, News

Corporate news to the archive Dermapharm continues its profitable growth in 2019 »          Group revenue of EUR 701 million in 2019, around 23% higher than in the previous year »          Adjusted EBITDA increases by approx. 24% compared to last year to EUR 178...
May 19, 2020 | Dermapharm Holding SE: Growth in the first quarter of 2020 despite the corona pandemic

February, 5 2020 | Dermapharm opens new logistics center in Brehna

by Nicolas Oberndorfer | Feb 5, 2020 | Dermapharm Corporate News, News

Corporate News to the archive Dermapharm opens new logistics center in Brehna Centralisation of logistics and expansion of the production space to approximately 12,000 m2 Short distances between production and logistics ensure the best possible availability of goods...
« Older Entries
Next Entries »
  • cometis
  • Services
  • Newsroom
  • Events
  • Shop
  • ESG Friday
  • News & Reports
  • Videos
  • Investor Relations
  • ESG
  • IPO
  • Bond
  • M&A
  • Crisis Communication
  • PR/ Public Affairs
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

© 2023 cometis AG – accelerate your impact

  • Contact
  • Privacy Policy
  • Legal Notice
  • Contact
  • Privacy Policy
  • Legal Notice

© 2023 cometis AG – accelerate your impact